NewsWhore
09-28-2009, 07:20 AM
-0.34% to register and commercialize its Cimzia drug in Brazil. The drug is to be registered for the treatment of rheumatoid arthritis and Crohn's disease. Under the agreement, AstraZeneca will regist...
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/28264614/)
More... (http://story.brazilsun.com/index.php/ct/9/cid/24437442923341f1/id/28264614/)